These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Confounding by indication and channeling over time: the risks of beta 2-agonists. Blais L, Ernst P, Suissa S. Am J Epidemiol; 1996 Dec 15; 144(12):1161-9. PubMed ID: 8956629 [Abstract] [Full Text] [Related]
54. Fenoterol: enough is enough. Garrett JE, Lanes S, Kolbe J, Rea HH. N Z Med J; 1992 Oct 14; 105(943):414. PubMed ID: 1461600 [No Abstract] [Full Text] [Related]
55. The New Zealand asthma mortality epidemic. Beasley R, Burgess C, Crane J, Pearce N. Clin Sci (Lond); 1995 Jan 14; 88(1):14-7. PubMed ID: 7704993 [No Abstract] [Full Text] [Related]
58. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Pearce N, Grainger J, Atkinson M, Crane J, Burgess C, Culling C, Windom H, Beasley R. Thorax; 1990 Mar 14; 45(3):170-5. PubMed ID: 2330548 [Abstract] [Full Text] [Related]